| | | | | |
NAUT Nautilus Biotechnolgy, Inc. Common Stock | $2,0650 | +3,25 % | $254,15M | $7,70M | |
OTLK Outlook Therapeutics, Inc. Common Stock | $1,7100 | +0,00 % | $254,08M | $11,49M | |
SIDU Sidus Space, Inc. Class A Common Stock | $2,6300 | +0,77 % | $254,08M | $25,01M | |
GLO Clough Global Opportunities Fund | $5,9400 | +0,00 % | $254,03M | $67,18K | |
OBIO Orchestra BioMed Holdings, Inc. Ordinary Shares | $4,2450 | +0,12 % | $253,89M | $5,42M | |
FULC Fulcrum Therapeutics, Inc. Common Stock | $3,8100 | +0,26 % | $253,20M | $4,93M | |
IKT Inhibikase Therapeutics, Inc. Common Stock | $1,8900 | -1,05 % | $252,18M | $3,82M | |
FCT First Trust Senior Floating Rate Income Fund II | $9,7000 | +0,00 % | $252,03M | $190,52K | |
ATGL Alpha Technology Group Limited Class A Ordinary Shares | $11,5000 | +0,26 % | $251,62M | $749,00 | |
ACRE Ares Commercial Real Estate Corporation | $4,5100 | +0,00 % | $250,21M | $1,28M | |
SCII SC II Acquisition Corp. Class A ordinary share | $10,0500 | +0,00 % | $249,22M | $90,21K | |
USAU U.S. Gold Corp. Common Stock | $15,0500 | -0,13 % | $248,67M | $585,72K | |
RCS PIMCO STRATEGIC INCOME FUND, INC. | $5,2600 | +0,00 % | $248,39M | $117,21K | |
EVGO EVgo Inc. Class A Common Stock | $1,7700 | +0,57 % | $248,26M | $7,42M | |
QADR QDRO Acquisition Corp. Class A Ordinary Shares | $9,9000 | -0,25 % | $248,12M | $206,00 | |
